|
Jubilant Pharmova Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
13729.24 Cr.
|
P/BV
|
2.31
|
Book Value (Rs.)
|
372.96
|
|
52 Week High/Low (Rs.)
|
1310/617
|
FV/ML
|
1/1
|
P/E(X)
|
178.07
|
|
Bookclosure
|
02/08/2024
|
EPS (Rs.)
|
4.84
|
Div Yield (%)
|
0.58
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 4.87 | -3.83 | 26.00 | 52.48 | 56.39 |
| Diluted EPS (Rs.) | 4.86 | -3.83 | 26.00 | 52.48 | 56.39 |
| Cash EPS (Rs.) | 27.25 | 29.98 | 50.55 | 73.70 | 77.72 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 343.11 | 338.91 | 333.97 | 297.85 | 351.78 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 343.11 | 338.91 | 333.97 | 297.85 | 351.78 |
| Revenue From Operations / Share (Rs.) | 424.23 | 394.85 | 385.08 | 383.10 | 375.13 |
| PBDIT / Share (Rs.) | 61.36 | 51.20 | 73.35 | 88.83 | 99.52 |
| PBIT / Share (Rs.) | 37.19 | 16.38 | 49.37 | 66.91 | 78.19 |
| PBT / Share (Rs.) | 9.27 | 0.97 | 40.23 | 54.01 | 63.58 |
| Net Profit / Share (Rs.) | 3.08 | -4.85 | 26.57 | 51.78 | 56.39 |
| NP After MI And SOA / Share (Rs.) | 4.88 | -3.83 | 26.00 | 52.51 | 56.39 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 14.46 | 12.96 | 19.04 | 23.18 | 26.52 |
| PBIT Margin (%) | 8.76 | 4.14 | 12.82 | 17.46 | 20.84 |
| PBT Margin (%) | 2.18 | 0.24 | 10.44 | 14.09 | 16.94 |
| Net Profit Margin (%) | 0.72 | -1.22 | 6.90 | 13.51 | 15.03 |
| NP After MI And SOA Margin (%) | 1.15 | -0.97 | 6.75 | 13.70 | 15.03 |
| Return on Networth / Equity (%) | 1.41 | -1.12 | 7.78 | 17.62 | 16.02 |
| Return on Capital Employeed (%) | 6.08 | 2.77 | 9.35 | 13.53 | 12.57 |
| Return On Assets (%) | 0.66 | -0.54 | 4.14 | 9.37 | 7.17 |
| Long Term Debt / Equity (X) | 0.58 | 0.57 | 0.46 | 0.54 | 0.66 |
| Total Debt / Equity (X) | 0.62 | 0.63 | 0.55 | 0.54 | 0.78 |
| Asset Turnover Ratio (%) | 0.59 | 0.59 | 0.01 | 0.37 | 0.37 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 2.05 | 2.12 | 2.20 | 2.81 | 1.92 |
| Quick Ratio (X) | 1.37 | 1.34 | 1.42 | 1.74 | 1.22 |
| Inventory Turnover Ratio (X) | 1.36 | 1.26 | 0.00 | 1.44 | 1.62 |
| Dividend Payout Ratio (NP) (%) | 103.24 | -130.60 | 19.23 | 0.00 | 16.84 |
| Dividend Payout Ratio (CP) (%) | 17.34 | 16.15 | 10.00 | 0.00 | 12.22 |
| Earning Retention Ratio (%) | -3.24 | 230.60 | 80.77 | 0.00 | 83.16 |
| Cash Earning Retention Ratio (%) | 82.66 | 83.85 | 90.00 | 0.00 | 87.78 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 3.56 | 4.33 | 8.03 | 7.68 | 7.94 |
| Interest Coverage Ratio (Post Tax) (%) | 1.80 | 0.89 | 3.91 | 4.17 | 4.56 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 11426.80 | 6827.69 | 8114.60 | 12743.97 | 6953.89 |
| EV / Net Operating Revenue (X) | 1.70 | 1.09 | 1.32 | 2.09 | 1.16 |
| EV / EBITDA (X) | 11.79 | 8.38 | 6.95 | 9.01 | 4.39 |
| MarketCap / Net Operating Revenue (X) | 1.34 | 0.70 | 1.01 | 1.78 | 0.66 |
| Retention Ratios (%) | -3.24 | 230.60 | 80.76 | 0.00 | 83.15 |
| Price / BV (X) | 1.65 | 0.82 | 1.16 | 2.28 | 0.70 |
| Price / Net Operating Revenue (X) | 1.34 | 0.70 | 1.01 | 1.78 | 0.66 |
| EarningsYield | 0.01 | -0.01 | 0.06 | 0.07 | 0.22 |
